Target intelligence / Profile preview

T helper type 1 cytokine secretion (Th1 cytokine secretion)

Target
Th1 cytokine secretion
Molecular classification
Other (cellular process, not a single molecule or receptor)
01

Overview

T helper type 1 cytokine secretion" refers to the process by which **T helper type 1 cells** (Th1 cells), a subset of CD4+ T lymphocytes, produce and secrete specific pro-inflammatory cytokines. The primary cytokines secreted by Th1 cells include **interferon gamma (IFNγ)**, **tumor necrosis factor alpha/beta (TNFα/β)**, and interleukin 2 (**IL2**)[5][7][8]. These secreted factors are crucial for activating macrophages, enhancing their microbicidal activity against intracellular pathogens such as Mycobacterium tuberculosis[3][5]. The differentiation of naive CD4+ T cells into the Th1 lineage is driven mainly by exposure to IL12 and IFNγ in the local environment during antigen presentation; this process involves key transcription factors such as STAT4 and T-bet[1][6]. While essential for protective immunity against many infections and tumors, dysregulated or excessive Th1-type responses are implicated in various autoimmune diseases—including Crohn's disease, organ-specific autoimmunity—and chronic inflammatory conditions[7]. Note on correctness ("is_incorrect"): "T helper cell type 1 cytokine secretion" is not itself a molecular target but rather describes a cellular function or process. It does not refer to a single protein, receptor, enzyme, or druggable entity but instead encompasses the collective action of multiple molecules produced by differentiated immune cells. For structured databases focused on molecular targets suitable for pharmacological intervention—such as receptors or enzymes—this entry would be considered incorrect or too broad[5][7].

Other names
Th1 cytokine productionType 1 helper T cell cytokine releaseTh1 cell effector function
02

Biological functions

Immune responseCytokine productionMacrophage activationCell-mediated immunity
03

Disease associations

InflammationAutoimmune diseaseInfection (especially intracellular pathogens)Cancer (tumor immunity)
04

Safety considerations

Excessive Th1 responses can contribute to autoimmune diseases and tissue damage[7].
05

Biomarkers

Interferon gamma (IFNγ)Tumor necrosis factor alpha (TNFα)

Beyond the preview

Go deeper on T helper type 1 cytokine secretion (Th1 cytokine secretion).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T helper type 1 cytokine secretion (Th1 cytokine secretion).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call